Biosimilars and Interchangeable Biologics: Tactical Elements (Volume 1)

 
9781498743495: Biosimilars and Interchangeable Biologics: Tactical Elements (Volume 1)
View all copies of this ISBN edition:
 
 

What’s the Deal with Biosimilars?

Biosimilars are gaining momentum as new protein therapeutic candidates that can help fill a vital need in the healthcare industry. The biological drugs are produced by recombinant DNA technology that allows for large-scale production and an overall reduction time in costs and development.

Part of a two-volume set that covers varying aspects of biosimilars, Biosimilars and Interchangeable Biologics: Tactical Elements explores the development and manufacturing of biosimilars and targets challenges surrounding the creation of these products. This includes manufacturing, production costs, and intellectual property barriers, particularly in regulated markets (regulatory agencies are still in the process of developing guidelines). It addresses the complexity of biological drugs, and it discusses specific structural elements vital to the functionality, immunogenicity, and safety of biosimilar products.

Of specific interest to practitioners, researchers, and scientists in the biopharmaceutical industry, this volume provides an overall understanding of the hurdles, difficulties, and practicalities of developing a strong plan. It introduces a step-by-step approach for creating a strategy that helps develop and manufacture a biosimilar product while reducing overall production costs and meeting the requirements of biosimilarity based on analytical and functional, pharmacokinetic, pharmacodynamic (where applicable), and nonclinical toxicology or toxicokinetic similarity (where appropriate) while remaining competitive in the market.

"synopsis" may belong to another edition of this title.

About the Author:

Sarfaraz K. Niazi, PhD, is the founding executive chairman of Therapeutic Proteins International LLC, a world-class pure-play developer and manufacturer of biosimilar and interchangeable recombinant biologics, headquartered in Chicago. Dr. Niazi began his career teaching pharmacy at the University of Illinois (1972–1988), where he became a tenured professor. He then entered the pharmaceutical industry at Abbott International, becoming a Volwiler Fellow. He left Abbott in 1995 with a passion for making high-cost biological drugs affordable. Dr. Niazi set up several ex-U.S. biosimilar companies and, in 2003, established Therapeutic Proteins International, the only U.S. integrated company of its kind to date.

"About this title" may belong to another edition of this title.

Buy New View Book
List Price: US$ 200.00
US$ 187.16

Convert Currency

Shipping: US$ 2.64
Within U.S.A.

Destination, Rates & Speeds

Add to Basket

Top Search Results from the AbeBooks Marketplace

1.

Niazi, Sarfaraz K.
ISBN 10: 1498743498 ISBN 13: 9781498743495
New Quantity Available: 5
Seller:
GreatBookPrices
(Columbia, MD, U.S.A.)
Rating
[?]

Book Description Condition: New. Seller Inventory # 24708005-n

More information about this seller | Contact this seller

Buy New
US$ 187.16
Convert Currency

Add to Basket

Shipping: US$ 2.64
Within U.S.A.
Destination, Rates & Speeds

2.

Niazi, Sarfaraz
ISBN 10: 1498743498 ISBN 13: 9781498743495
New Quantity Available: 1
Seller:
Paperbackshop-US
(Wood Dale, IL, U.S.A.)
Rating
[?]

Book Description 2015. HRD. Condition: New. New Book. Shipped from US within 10 to 14 business days. Established seller since 2000. Seller Inventory # KS-9781498743495

More information about this seller | Contact this seller

Buy New
US$ 186.69
Convert Currency

Add to Basket

Shipping: US$ 3.99
Within U.S.A.
Destination, Rates & Speeds

3.

Sarfaraz K. Niazi
Published by Taylor Francis Inc, United States (2015)
ISBN 10: 1498743498 ISBN 13: 9781498743495
New Hardcover Quantity Available: 1
Seller:
Book Depository International
(London, United Kingdom)
Rating
[?]

Book Description Taylor Francis Inc, United States, 2015. Hardback. Condition: New. Language: English . Brand New Book. What s the Deal with Biosimilars? Biosimilars are gaining momentum as new protein therapeutic candidates that can help fill a vital need in the healthcare industry. The biological drugs are produced by recombinant DNA technology that allows for large-scale production and an overall reduction time in costs and development. Part of a two-volume set that covers varying aspects of biosimilars, Biosimilars and Interchangeable Biologics: Tactical Elements explores the development and manufacturing of biosimilars and targets challenges surrounding the creation of these products. This includes manufacturing, production costs, and intellectual property barriers, particularly in regulated markets (regulatory agencies are still in the process of developing guidelines). It addresses the complexity of biological drugs, and it discusses specific structural elements vital to the functionality, immunogenicity, and safety of biosimilar products. Of specific interest to practitioners, researchers, and scientists in the biopharmaceutical industry, this volume provides an overall understanding of the hurdles, difficulties, and practicalities of developing a strong plan. It introduces a step-by-step approach for creating a strategy that helps develop and manufacture a biosimilar product while reducing overall production costs and meeting the requirements of biosimilarity based on analytical and functional, pharmacokinetic, pharmacodynamic (where applicable), and nonclinical toxicology or toxicokinetic similarity (where appropriate) while remaining competitive in the market. Seller Inventory # AAS9781498743495

More information about this seller | Contact this seller

Buy New
US$ 206.89
Convert Currency

Add to Basket

Shipping: FREE
From United Kingdom to U.S.A.
Destination, Rates & Speeds

4.

Sarfaraz K. Niazi
Published by Taylor Francis Inc, United States (2015)
ISBN 10: 1498743498 ISBN 13: 9781498743495
New Hardcover Quantity Available: 1
Seller:
The Book Depository
(London, United Kingdom)
Rating
[?]

Book Description Taylor Francis Inc, United States, 2015. Hardback. Condition: New. Language: English . Brand New Book. What s the Deal with Biosimilars? Biosimilars are gaining momentum as new protein therapeutic candidates that can help fill a vital need in the healthcare industry. The biological drugs are produced by recombinant DNA technology that allows for large-scale production and an overall reduction time in costs and development. Part of a two-volume set that covers varying aspects of biosimilars, Biosimilars and Interchangeable Biologics: Tactical Elements explores the development and manufacturing of biosimilars and targets challenges surrounding the creation of these products. This includes manufacturing, production costs, and intellectual property barriers, particularly in regulated markets (regulatory agencies are still in the process of developing guidelines). It addresses the complexity of biological drugs, and it discusses specific structural elements vital to the functionality, immunogenicity, and safety of biosimilar products. Of specific interest to practitioners, researchers, and scientists in the biopharmaceutical industry, this volume provides an overall understanding of the hurdles, difficulties, and practicalities of developing a strong plan. It introduces a step-by-step approach for creating a strategy that helps develop and manufacture a biosimilar product while reducing overall production costs and meeting the requirements of biosimilarity based on analytical and functional, pharmacokinetic, pharmacodynamic (where applicable), and nonclinical toxicology or toxicokinetic similarity (where appropriate) while remaining competitive in the market. Seller Inventory # AAS9781498743495

More information about this seller | Contact this seller

Buy New
US$ 213.62
Convert Currency

Add to Basket

Shipping: FREE
From United Kingdom to U.S.A.
Destination, Rates & Speeds

5.

Sarfaraz K. Niazi
ISBN 10: 1498743498 ISBN 13: 9781498743495
New Hardcover Quantity Available: 1
Seller:
Grand Eagle Retail
(Wilmington, DE, U.S.A.)
Rating
[?]

Book Description 2015. Hardcover. Condition: New. Hardcover. What's the Deal with Biosimilars?Biosimilars are gaining momentum as new protein therapeutic candidates that can help fill a vital need in the healthcare industry. The biological drugs are.Shipping may be from multiple locations in the US or from the UK, depending on stock availability. 623 pages. 2.222. Seller Inventory # 9781498743495

More information about this seller | Contact this seller

Buy New
US$ 216.70
Convert Currency

Add to Basket

Shipping: FREE
Within U.S.A.
Destination, Rates & Speeds

6.

Sarfaraz K. Niazi
ISBN 10: 1498743498 ISBN 13: 9781498743495
New Quantity Available: 3
Seller:
Majestic Books
(London, ,, United Kingdom)
Rating
[?]

Book Description Condition: New. pp. 672. Seller Inventory # 373573074

More information about this seller | Contact this seller

Buy New
US$ 216.81
Convert Currency

Add to Basket

Shipping: US$ 7.36
From United Kingdom to U.S.A.
Destination, Rates & Speeds

7.

NIAZI, SARFARAZ K.
Published by CRC Press (2015)
ISBN 10: 1498743498 ISBN 13: 9781498743495
New Hardcover Quantity Available: 1
Seller:
Herb Tandree Philosophy Books
(Stroud, GLOS, United Kingdom)
Rating
[?]

Book Description CRC Press, 2015. Hardback. Condition: NEW. 9781498743495 This listing is a new book, a title currently in-print which we order directly and immediately from the publisher. For all enquiries, please contact Herb Tandree Philosophy Books directly - customer service is our primary goal. Seller Inventory # HTANDREE0970856

More information about this seller | Contact this seller

Buy New
US$ 219.86
Convert Currency

Add to Basket

Shipping: US$ 10.71
From United Kingdom to U.S.A.
Destination, Rates & Speeds

8.

Niazi, Sarfaraz K.
Published by CRC Pr I Llc (2015)
ISBN 10: 1498743498 ISBN 13: 9781498743495
New Hardcover Quantity Available: 1
Seller:
Revaluation Books
(Exeter, United Kingdom)
Rating
[?]

Book Description CRC Pr I Llc, 2015. Hardcover. Condition: Brand New. 1st edition. 575 pages. 11.25x8.75x1.50 inches. In Stock. Seller Inventory # __1498743498

More information about this seller | Contact this seller

Buy New
US$ 239.49
Convert Currency

Add to Basket

Shipping: US$ 8.03
From United Kingdom to U.S.A.
Destination, Rates & Speeds

9.

Sarfaraz K. Niazi
Published by Taylor Francis Inc, United States (2015)
ISBN 10: 1498743498 ISBN 13: 9781498743495
New Hardcover Quantity Available: 1
Seller:
Book Depository hard to find
(London, United Kingdom)
Rating
[?]

Book Description Taylor Francis Inc, United States, 2015. Hardback. Condition: New. Language: English . This book usually ship within 10-15 business days and we will endeavor to dispatch orders quicker than this where possible. Brand New Book. What s the Deal with Biosimilars? Biosimilars are gaining momentum as new protein therapeutic candidates that can help fill a vital need in the healthcare industry. The biological drugs are produced by recombinant DNA technology that allows for large-scale production and an overall reduction time in costs and development. Part of a two-volume set that covers varying aspects of biosimilars, Biosimilars and Interchangeable Biologics: Tactical Elements explores the development and manufacturing of biosimilars and targets challenges surrounding the creation of these products. This includes manufacturing, production costs, and intellectual property barriers, particularly in regulated markets (regulatory agencies are still in the process of developing guidelines). It addresses the complexity of biological drugs, and it discusses specific structural elements vital to the functionality, immunogenicity, and safety of biosimilar products. Of specific interest to practitioners, researchers, and scientists in the biopharmaceutical industry, this volume provides an overall understanding of the hurdles, difficulties, and practicalities of developing a strong plan. It introduces a step-by-step approach for creating a strategy that helps develop and manufacture a biosimilar product while reducing overall production costs and meeting the requirements of biosimilarity based on analytical and functional, pharmacokinetic, pharmacodynamic (where applicable), and nonclinical toxicology or toxicokinetic similarity (where appropriate) while remaining competitive in the market. Seller Inventory # BTE9781498743495

More information about this seller | Contact this seller

Buy New
US$ 248.09
Convert Currency

Add to Basket

Shipping: FREE
From United Kingdom to U.S.A.
Destination, Rates & Speeds

10.

Sarfaraz K. Niazi
ISBN 10: 1498743498 ISBN 13: 9781498743495
New Hardcover Quantity Available: 1
Seller:
AussieBookSeller
(SILVERWATER, NSW, Australia)
Rating
[?]

Book Description 2015. Hardcover. Condition: New. Hardcover. What's the Deal with Biosimilars?Biosimilars are gaining momentum as new protein therapeutic candidates that can help fill a vital need in the healthcare industry. The biologi.Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability. 623 pages. 2.222. Seller Inventory # 9781498743495

More information about this seller | Contact this seller

Buy New
US$ 212.65
Convert Currency

Add to Basket

Shipping: US$ 37.00
From Australia to U.S.A.
Destination, Rates & Speeds

There are more copies of this book

View all search results for this book